Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy

OBJECTIVE: We review the historical regulation of drug compounding, concerns about widespread use of non-Food and Drug Admiistration (FDA)-approved compounded bioidentical hormone therapies (CBHTs), which do not have proper labeling and warnings, and anticipated impact of the 2013 Drug Quality and S...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinkerton, JoAnn V., Pickar, James H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2016
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927324/
https://www.ncbi.nlm.nih.gov/pubmed/26418479
http://dx.doi.org/10.1097/GME.0000000000000523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927324/
https://www.ncbi.nlm.nih.gov/pubmed/26418479
http://dx.doi.org/10.1097/GME.0000000000000523

Ejemplares similares